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ABSTRACT 
We assessed the self-reported prevalence of influenza-like illness (ILI) during pregnancy in 
two samples of 546 and 2,764 new mothers who were pregnant during the 2009 – 10 and 
2010 – 11 peak influenza seasons. During pregnancy, 11% of participants experienced an ILI. 
Cough, sore throat and nasal congestion were the most common reported symptoms. Only 
4.6% and 9% of participants in sample 1 and 2 had an underlying chronic illness respectively 
and 3.3% of mothers in both groups were smokers. Conducting regular surveillance on 
influenza prevalence during pregnancy is essential to evaluate the costs and benefits of 
influenza vaccination programmes.  
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INTRODUCTION 
The latest position paper from the World Health Organization (WHO) on seasonal influenza 
vaccination states that the highest priority for vaccination should be pregnant women (1). The 
recommendation is based on the excess risk of influenza-related morbidity and mortality in 
this group, the safety of the influenza vaccine throughout the pregnancy, and the vaccine’s 
effectiveness in reducing the risk of influenza and its complications among pregnant women 
and infants up to six month of age. However, existing evidence on the burden of seasonal 
influenza infection during pregnancy is largely based on studies from Western countries, and 
there is little evidence from other regions such as Asia. Pregnant women in various countries 
may have different susceptibility to influenza infection due to variation in the prevalence of 
risk factors in the population, such as underlying chronic illnesses, obesity, and smoking 
patterns. Therefore, assessing the prevalence of influenza and influenza-like-illness among 
pregnant women in different populations is important to evaluate the population level burden 
of influenza infection among pregnant women.  
 
Moreover, community-based influenza surveillance focusing on pregnant women is essential 
to provide baseline information regarding influenza activity and in evaluating the potential 
benefits of influenza vaccination programmes. To our knowledge, only one previous study 
conducted in 2002 has actually reported the prevalence of influenza-like-illness among 
pregnant women (2). Therefore, the aims of this analysis were to assess the prevalence of 
influenza-like illness (ILI) among Chinese pregnant women and to examine its association 
with potential risk factors and adverse pregnancy outcomes.  
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METHODS 
This paper included two large samples of postpartum women from the postnatal wards of 
public hospitals providing obstetric services in Hong Kong. Briefly, eligible participants were 
Hong Kong Chinese mothers, 18 years old or above, and had just given birth to a live 
newborn. The first sample of participants were recruited from February to June 2010 during 
the second wave of A/H1N1 influenza pandemic and included only those mothers with no 
serious medical and obstetric complications (i.e., infant admitted to the neonatal intensive 
care unit, congenital anomalies or birth defects, born at <37 weeks, or birth weight <2,500g). 
In this study, we recruited 549 participants from four study sites. Between April and June 
2011, we further recruited 2,846 postpartum participants from the postnatal wards of all eight 
public hospitals. A detailed description of the study methods of both studies is available 
elsewhere (3-4). Participants in both samples were pregnant throughout the winter influenza 
season, which theoretically increases the sensitivity and specificity of the case definition. 
Data were collected using a self-completed questionnaire assessing socio-demographic 
characteristics, maternal influenza vaccination status, maternal and paternal smoking patterns, 
pre-existing chronic illnesses, medical conditions arising during pregnancy, and the 
occurrence of respiratory and febrile illnesses during pregnancy.  
 
The primary outcomes were the prevalence of ILI during the 2009 – 2010 and 2010 – 2011 
influenza seasons. ILI was defined based on the febrile acute respiratory illness definition for 
influenza surveillance from the WHO, which defines ILI as the presence of fever plus cough 
or sore throat (5). We also examined at potential risk factors for ILI (i.e., maternal and 
paternal smoking status, seasonal and H1N1 influenza vaccination status, and underlying 
chronic illnesses and adverse pregnancy outcomes, defined as emergency caesarean section 
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(yes/no), preterm birth (<37 weeks gestation) and low birth weight (<2500 grams). Due to the 
historical low prevalence rate of obesity in Hong Kong, we did not assess BMI among 
pregnant women in either sample (6,7). Since we only included mothers without pregnancy 
complications in the first sample, no data on preterm birth or low birth weight is available for 
this group.  
 
Descriptive statistics were used to assess the prevalence of self-reported ILI and logistic 
regression was used to assess the unadjusted and fully adjusted associations between ILI and 
both background risk factors and adverse pregnancy outcomes. All data analysis was 
conducted using Stata 13 (Stata Corp, College Station, TX).  Ethical approval was obtained 
from the Institutional Review Boards of all participating institutions and informed written 
consent was obtained from all participants. 
 
RESULTS 
Complete data were available for 546 (99.5%) of the 549 recruited participants in the 2009 – 
2010 sample and 2,764 (97.1%) of the 2,846 participants in the 2010 – 2011 sample. The 
demographic characteristics of the study participants are presented in Table 1. Overall, 
sample 1 and 63% in sample 2 were 25 to 34 years of age, 67% in sample 1 and 63% in 
sample 2 were born in Hong Kong, only 3% were current smokers in both groups. Five 
percent (n = 25) and 9% (n = 254) had underlying chronic illnesses respectively, of which 
36% (n = 9) and 28% (n = 72) were chronic respiratory illnesses. Of all participants, 11% of 
participants in both groups reported having an ILI in pregnancy. Since the participants in 
sample 1 were pregnant during the second wave of 2009 A/H1N1 influenza pandemic, their 
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seasonal influenza vaccination rate was marginally higher than the second sample (5.0% vs 
1.7%). Cough, sore throat and nasal congestion were the three most common respiratory 
symptoms reported. In the fully adjusted analysis, only paternal smoking status during 
pregnancy was significantly associated with the risk of ILI (Table 2) while there were no 
significant associations between ILI and pregnancy outcomes (Table 3). 
 
DISCUSSION 
To our knowledge, this is the first report on the population-based prevalence of ILI among 
Chinese pregnant women and only the second report on this topic in any population. Our 
results consistently show a low rate of ILI (11%) among Hong Kong women during 
pregnancy across two influenza seasons in 2009 – 10 and 2010 – 11. In comparison, 
Tuyishime reported that 64% of Canadian women experienced a febrile ILI during pregnancy 
(2), an almost six-fold difference. However, Tuyishime’s study adopted a somewhat broader 
ILI definition (any combination of respiratory symptoms with fever). Upon reclassification of 
our data using Tuyishime’s broader ILI definition, the prevalence remained unchanged at 
11%. The substantial differences in the ILI rates between the two populations can possibly be 
explained by the presence of other risk factors such as pre-existing health conditions, obesity, 
and smoking rates among pregnant women. One US study found that 27% of pregnant 
women reported at least one chronic illness (7) compared with 5 to 9% in Hong Kong in our 
studies. In addition, the prevalence of obesity and maternal smoking in Asia are much lower 
than most Western countries. WHO data show that age-standardized obesity (BMI >30.0) 
estimates among adult women are 33% in the US, 25% in Australia and the United Kingdom, 
24% in Canada, and 15% in France and Italy compared with 7% in China and Indonesia, 6% 
in Singapore, and only 4% in Japan. In addition, the age-standardized prevalence of smoking 
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among adult females was 32% in France, 22% in the UK, and 17% in the US, while Asia 
Pacific rates were substantially lower at 11% in Japan, 4% in Singapore, 2% in China and 
Thailand, and 1% in Malaysia and Vietnam (8).   
 
Furthermore, while current evidence suggests that pregnant women are at higher risk of 
seasonal influenza-related morbidity, mortality, and adverse obstetric outcomes, it is not clear 
how much of this evidence is from studies conducted in Asia. During the 2009 A/H1N1 
influenza pandemic, outcomes for infected pregnant women in Asia were much more 
favourable than in Western countries. In Hong Kong, up until May 2010, 87 pregnant women 
infected with 2009 A/H1N1 influenza were hospitalized, and only one required mechanical 
ventilation and none died (9). In Singapore, 211 A/H1N1 laboratory-confirmed pregnant 
women presented to a hospital between May and September, 2009; only two cases were 
complicated by pneumonia and both recovered uneventfully (10).  In Japan, 181 pregnant 
women required hospitalization and none died (11) and only five Korean pregnant women 
were admitted to hospital and one died (12).  
 
This study has several limitations. The data reported here was a secondary analysis of two 
studies designed to examine uptake and predictors of maternal influenza vaccination and was 
not designed specifically to measure the burden of influenza infection of ILI during 
pregnancy. Recall bias may also be an issue since the study outcome data was collected 
retrospectively through self-report in the first 24 to 48 hours after birth when participants 
may be less able to recall events that happened earlier in the pregnancy. Research has shown, 
however, that maternal recall of events during pregnancy is reliable and accurate (13) and this 
is especially likely to be true with regard to febrile illness during pregnancy. In addition, this 
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study did not assess laboratory-confirmed influenza and therefore, the true prevalence of 
influenza infection may actually be lower. Although our results show no association between 
ILI during pregnancy and adverse pregnancy outcomes, it is possible that mothers with 
preterm or low birth weight infants may have been less willing to participate in the study and 
thus were under sampled.  
 
Determining the actual burden of influenza infection in high-risk populations is important to 
facilitate the planning of effective influenza vaccination programmes and other primary 
preventive interventions. WHO recommends that regional governments establish sustainable 
and effective surveillance systems to assess the epidemiology of influenza in high-risk groups, 
such as pregnant women and chronically ill individuals (1). In regions where the burden of 
influenza among pregnant women may be low, this type of surveillance is necessary so that 
resources are allocated to the groups with the highest needs. In the case of maternal 
vaccination programmes, it is also important to assess the burden of influenza infection in 
newborns under 6 months of age as the benefits of maternal vaccination for this group may 
provide a more substantial rationale for vaccination programmes.  
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Table 1 Characteristics of participants  
Variable  Sample 1  Sample 2  N wt %  N wt % 
Total   546 100.0  2,764 100.0 
       
Age         
18 - 24 years  41 7.5  263 9.5 
25 - 29 years  131 24.0  716 25.9 
30 - 34 years  247 45.2  1,027 37.2 
≥ 35 years  127 23.3  758 27.4 
          
Education         
Compulsory secondary  276 50.6  1,649 59.7 
Upper secondary  107 19.6  488 17.7 
University degree or above  163 29.9  627 22.7 
          
Place of birth         
Hong Kong  367 67.2  1,735 62.8 
Mainland China  167 30.6  968 35.0 
Other  12 2.2  61 2.2 
          
Smoking status during pregnancy         
No  528 96.7  2,674 96.7 
Yes  18 3.3  90 3.3 
          
Partner's smoking status during pregnancy         
No  374 68.5  1,855 67.1 
Yes  172 31.5  909 32.9 
          
Seasonal influenza vaccination status during pregnancy         
No   519 95.1  2,716 98.3 
Yes  27 5.0  48 1.7 
          
H1N1 influenza vaccination status during pregnancy       
No  512 93.8  NA NA 
Yes  34 6.2  NA NA 
       
Pre-existing chronic illness         
No  521 95.4  2,510 90.8 
Yes   25 4.6  254 9.1 
Types: (some participants have more than one illness)       
Respiratory/ pulmonary disease  9 36.0  72 28.4 
Thyroid disease  4 16.0  42 16.5 
Hepatitis B   7 28.0  38 15.0 
Others  6 24.0  120 47.2 
       
Emergency caesarian section         
No  498 91.2  2,412 87.3 
Yes  48 8.8  352 12.7 
          
Preterm birth (<37 weeks gestation)         
No  NA NA  2,550 92.3 
Yes  NA NA  214 7.7 
          
Low birth weight infant (<2500 gms)         
No  NA NA  2,548 92.2 
Yes  NA NA  216 7.8 
NA=not available
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Table 2 Unadjusted and adjusted odds ratios for risk of ILI with regards to potential risk factors 
 Sample 1  Sample 2 
Variable 
Unadjusted ILI  Adjusted ILI1  Unadjusted ILI  Adjusted ILI1 
OR 95% CI Sig.  AOR 95% CI Sig.  OR 95% CI Sig.  AOR 95%CI Sig. 
Smoking status during pregnancy                
    No 1    1    1    1   
    Yes 0.99 0.22, 4.43 0.99  0.95 0.21, 4.39 0.95  1.33 0.73, 2.42 0.36  1.15 0.62, 2.16 0.66 
                
Partner’s smoking status during pregnancy                
    No 1    1    1    1   
    Yes 0.82 0.46, 1.49 0.52  0.85 0.45, 1.60 0.61  1.11 0.87, 1.42 0.42  1.36 1.04, 1.79 0.03 
                
Seasonal influenza vaccine status in pregnancy                
    No  1    1    1    1   
    Yes 0.99 0.29, 3.40 0.99  0.65 0.16, 2.56 0.54  0.70 0.25, 1.97 0.50  0.62 0.22, 1.75 0.36 
                
H1N1 influenza vaccine status in pregnancy                
    No  1    1           
    Yes 2.20 0.91, 5.29 0.08  2.20 0.82, 5.92 0.12  NA NA NA  NA NA NA 
                
Pre-existing chronic illness                
    No  1    1    1    1   
    Yes 1.09 0.32, 3.75 0.89  1.00 0.28, 3.57 1.00  1.05 0.70, 1.56 0.83  1.06 0.71, 1.59 0.78 
                
1Adjusted for age group, educational level, place of birth, and the remaining variables in the table 
NA=not available
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Table 3 Unadjusted and adjusted ORs for the risk of selected maternal and neonatal outcomes with regard to ILI  in sample 2 
Variable 
  Emergency caesarian section   Preterm   Low birth weight 
  OR   95% CI Sig.   OR   95% CI Sig.   OR   95% CI Sig. 
Unadjusted ILI 
No   1         1         1       
Yes   1.03   0.73, 1.46 0.87   1.24   0.82, 1.87 0.30   1.23   0.81, 1.85 0.33 
                                
Adjusted ILI1 
No   1         1         1       
Yes   0.99   0.70, 1.42 0.93   1.23   0.81, 1.87 0.33   1.14   0.75, 1.73 0.55 
                                
1 Adjusted for age group, educational level, place of birth, family income, maternal smoking status, seasonal influenza vaccination status, pre-
existing chronic illness, and medical conditions arise during pregnancy 
NA = not available 
 
